Keith Grant Tolman MD

Dr. Tolman is a Professor of Medicine and Pharmacology at the University of Utah in Salt Lake City. He received his medical degree from the University of British Columbia in Vancouver, Canada followed by a residency at Baylor Medical University in Houston and a GI Fellowship at the University of Utah. He is Board Certified in Internal Medicine and Clinical Pharmacology. He later received post-doctoral training at the University of Queensland at the Royal Brisbane Hospital in Australia.

His entire academic career has been spent at the University of Utah where he has held positions as Chairman of Gastroenterology, Chief of Hepatology, and Director of Clinical Pharmacology. Professor Tolman is the author of more than 100 publications. His research interests have been primarily in gastrointestinal pharmacology and hepatotoxicity. He has authored several articles on diabetes-related liver disease, treatment of fatty liver disease, and the hepatotoxicity of drugs used in the treatment of diabetes. He serves on several Scientific Advisory Boards and has been a consultant to the US Food and Drug Administration as well as regulatory authorities in Australia and South Africa.